Moberg Pharma
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Gustavslundsvägen 42, Bromma, Stockholm,...Phone Number
+46 852230700Website
www.mobergpharma.comRevenue
$48 MillionStock Symbol
MOB.STIndustry
About Moberg Pharma
Moberg Pharma Org Chart
Is Moberg Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Moberg Pharma recently announced quarterly report
Moberg Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Moberg Pharma has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Moberg Pharma
Funding: Get notified immidiatlly once Moberg Pharma has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Moberg Pharma had a recent Job posting/layoffs
Check out if Moberg Pharma is spiking on competitors!
Product Launch: Get notified when Moberg Pharma launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Moberg Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Moberg Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Moberg Pharma.
Moberg Pharma Tech Stack
A closer look at the technologies used by Moberg Pharma
Most Recent Scoops
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Moberg Pharma
Moberg Pharma is a Swedish specialty pharmaceutical company focused on dermatology, developing innovative treatments for nail fungus. Their product, MOB-015, is a topical solution approved in 13 EU countries, aimed at improving treatment outcomes for patients suffering from onychomycosis. The company emphasizes strong clinical efficacy and ease of... Read More